2024 annual financial data
Vanda Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -20.46%.
Operating income was -40,660,000 USD and net income was -18,900,000 USD.
Operating cash flow was -15,757,000 USD.
Get free Vanda Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 198,772,000 USD
- Operating income
- -40,660,000 USD
- Net income
- -18,900,000 USD
- Operating cash flow
- -15,757,000 USD